Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay [2]

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 386-

  Yoshida, Eric M ^a   Sherlock, Christopher H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; LAMIVUDINE; VIRUS DNA;

CLINICAL ARTICLE; HEPATITIS B; HUMAN; HYBRIDIZATION; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; REINFECTION; STANDARDIZATION;

EID: 0034109697     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/lv.2000.6813     Document Type: Letter

References (3)

1. Yoshida E.M. Erb S.R. Parcovi N. Scudamore C.H. Chung S.W. Frighetto L. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin Liver Transpl Surg 5 1999 520 525
2. Tchervenkov J.I. Tecter A.J. Barkun J.S. Sherker A. Forbers C.D. Elias N. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulinposttransplant Ann Surg 226 1997 356 368
3. Yao F. Orsorio R.W. Roberts J.P. Poordad F.F. Briceno M.N. Garcia-Kennedy R. Gish R.B. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation Liver Transpl Surg 5 1999 491 496